Korro Bio, Inc. financial data

Symbol
KRRO on Nasdaq
Industry
Pharmaceutical Preparations
Location
60 First Street, 2 Nd Floor, Suite 250, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Frequency Therapeutics, Inc. (to 11/6/2023)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.12K % +152%
Return On Equity -50.3 % -228%
Return On Assets -38.5 % +41.6%
Operating Margin -925 % -655%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.37M shares -74.6%
Common Stock, Shares, Outstanding 9.32M shares -74.8%
Entity Public Float 12.1M USD -74%
Common Stock, Value, Issued 9K USD -75.7%
Weighted Average Number of Shares Outstanding, Basic 9.3M shares +3174%
Weighted Average Number of Shares Outstanding, Diluted 9.3M shares +3174%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 62.1M USD +37.2%
General and Administrative Expense 33.7M USD +412%
Operating Income (Loss) -95.8M USD -84.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87.8M USD -77.3%
Income Tax Expense (Benefit) 38K USD -17.4%
Net Income (Loss) Attributable to Parent -87.8M USD -77.2%
Earnings Per Share, Basic 141 USD/shares +96.5%
Earnings Per Share, Diluted 141 USD/shares +96.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 63.2M USD +51.5%
Marketable Securities, Current 73.8M USD
Other Assets, Current 255K USD +37.8%
Assets, Current 153M USD +259%
Property, Plant and Equipment, Net 29.1M USD +5261%
Operating Lease, Right-of-Use Asset 24M USD +1694%
Other Assets, Noncurrent 2.11M USD
Assets 244M USD +425%
Accounts Payable, Current 5.95M USD +1660%
Employee-related Liabilities, Current 1.87M USD -43.8%
Accrued Liabilities, Current 5.46M USD -30.4%
Liabilities, Current 13.6M USD +41.6%
Operating Lease, Liability, Noncurrent 41.8M USD
Other Liabilities, Noncurrent 717K USD
Liabilities 63.9M USD +565%
Accumulated Other Comprehensive Income (Loss), Net of Tax 574K USD +5640%
Retained Earnings (Accumulated Deficit) -245M USD +19.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 180M USD
Liabilities and Equity 244M USD +425%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.9M USD -11.2%
Net Cash Provided by (Used in) Financing Activities 139K USD -99.7%
Net Cash Provided by (Used in) Investing Activities -5.61M USD -136%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 9.32M shares -74.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -27.4M USD -166%
Deferred Tax Assets, Valuation Allowance 146M USD +304%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 153M USD +312%
Operating Lease, Liability 41.8M USD
Depreciation 3.55M USD +36.7%
Payments to Acquire Property, Plant, and Equipment 5.61M USD +271%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -20.4M USD -10.6%
Lessee, Operating Lease, Liability, to be Paid 71.9M USD
Property, Plant and Equipment, Gross 39M USD +974%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.34M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 6.25M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 30.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.56M USD
Deferred Tax Assets, Operating Loss Carryforwards 80.4M USD +311%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.56M USD +61.8%
Additional Paid in Capital 424M USD +24.7%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments Due, Next Twelve Months 4.27M USD +2.69%
Deferred Tax Assets, Net of Valuation Allowance 7.72M USD +587%
Share-based Payment Arrangement, Expense 4.33M USD +215%
Operating Leases, Future Minimum Payments, Due in Three Years 4.4M USD -0.23%
Operating Leases, Future Minimum Payments Due 40.2M USD -9.56%
Interest Expense 596K USD -28.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%